Announcements Trials
Browse Landscape

Phase

Phase 3 58Phase 2 56Phase 1 13Phase 2/3 5Phase NA 3Phase 1/2 3Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 12NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1

Interventions

venetoclax 1tafasitamab 1relugolix 1prednylidene 1glofitamab 1deltacortene 1daratumumab 1Vincristine 1Rituximab 1Prednisone 1Gemcitabine 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × NETWORK × Etoposide × Clear all
NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

AIDS Malignancy Consortium

Phase EARLY_PHASE1 Recruiting
15 enrolled
Lymphoid

Plasmablastic Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡